Menu
Not yet recruiting NCT07027449

Connecting People With Cancer to Employment Support

No phase Interventional Cancer

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Screening and Referral Workflow.
Who it may be relevant to
Registry conditions: Cancer. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Implementing Pathways to Identify and Address Employment Concerns Among People With Cancer Across Diverse Clinical Settings

Overview

The goal of this clinical trial is to learn if a clinical workflow that screens adult patients with cancer for challenges at work and refers them to supportive resources is feasible, appropriate, and acceptable to patients and staff members in 2 cancer care settings. The main questions it aims to answer are: Is the clinical workflow feasible and acceptable to participants? Are study procedures feasible and acceptable to participants? Patient participants will complete 2 surveys: 1 at the time of enrollment and 1 six months later.

Detailed description

Investigators will conduct a prospective single-arm study at 2 sites to pilot and iteratively adapt a clinical workflow intervention, implementation strategies, and associated study procedures. Investigators will implement the clinical workflow intervention across each study site, then recruit consecutive patients (n=50) to complete patient-reported measures at 2 time points (T1: enrollment; T2: 6-month follow-up. Investigators will recruit staff members (n=20) to complete survey measures at 2 time points (T1: beginning of pilot study period; T2: end of pilot study period).

Interventions

  • Behavioral Screening and Referral Workflow
    The Screening and Referral Workflow intervention will include screening eligible patients for employment-related needs and referring those who require support to community-based employment resources.

Primary outcome measures

  • Enrollment Rate [Time frame: Baseline]
  • Follow-up Survey Completion Rate [Time frame: 6 months]
  • Staff-reported Feasibility of Intervention [Time frame: Approximately 9 months]
  • Acceptability of Intervention: Staff [Time frame: Approximately 9 months]
  • Acceptability of Intervention: Patients [Time frame: Baseline; 6 months]
  • Employment Concerns Screening [Time frame: Baseline]
Secondary outcome measures (6)
  • Employment status [Time frame: Baseline; 6 months]
  • Sick leave duration [Time frame: Baseline; 6 months]
  • Health-related quality of life [Time frame: Baseline; 6 months]
  • Health insurance status [Time frame: Baseline; 6 months]
  • Self-efficacy [Time frame: Baseline; 6 months]
  • Financial toxicity [Time frame: Baseline; 6 months]

Eligibility criteria

Eligible Patients:

  • visiting a participating medical or radiation oncology clinic for new diagnosis, treatment, or follow-up of any type of cancer;
  • employed at the time of cancer diagnosis;
  • age 18 or older;
  • able to give full informed consent;
  • able to communicate in English or Spanish.

Eligible Staff:

  • age 18 or older;
  • employed at one of the participating clinical sites.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Health services research

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07027449 · STUDY00161657

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗